The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

R. Iacovelli, M. Cossu Rocca, L. Galli, R. Sabbatini, U. De Giorgi, D. Santini, G. Facchini, A. Mosca, F. Atzori, P. Zucali, G. Fornarini, F. Massari, S. Buti, R. Ricotta, C. Masini, I. Toscani, E. Biasco, A. Guida, C. Lolli, D. De LisiS. Rossetti, C. Terrone, M. Scartozzi, C. Miggiano, A. Pastorino, M. Bersanelli, G. Carlo-Stella, C. Pinto, E. Nobili, F. Nolè, G. Tortora, C. Porta

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)705-709
Number of pages5
JournalAnti-Cancer Drugs
Volume29
Issue number7
DOIs
Publication statusPublished - 2018

Cite this

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma. / Iacovelli, R.; Cossu Rocca, M.; Galli, L.; Sabbatini, R.; De Giorgi, U.; Santini, D.; Facchini, G.; Mosca, A.; Atzori, F.; Zucali, P.; Fornarini, G.; Massari, F.; Buti, S.; Ricotta, R.; Masini, C.; Toscani, I.; Biasco, E.; Guida, A.; Lolli, C.; De Lisi, D.; Rossetti, S.; Terrone, C.; Scartozzi, M.; Miggiano, C.; Pastorino, A.; Bersanelli, M.; Carlo-Stella, G.; Pinto, C.; Nobili, E.; Nolè, F.; Tortora, G.; Porta, C.

In: Anti-Cancer Drugs, Vol. 29, No. 7, 2018, p. 705-709.

Research output: Contribution to journalArticle

Iacovelli, R, Cossu Rocca, M, Galli, L, Sabbatini, R, De Giorgi, U, Santini, D, Facchini, G, Mosca, A, Atzori, F, Zucali, P, Fornarini, G, Massari, F, Buti, S, Ricotta, R, Masini, C, Toscani, I, Biasco, E, Guida, A, Lolli, C, De Lisi, D, Rossetti, S, Terrone, C, Scartozzi, M, Miggiano, C, Pastorino, A, Bersanelli, M, Carlo-Stella, G, Pinto, C, Nobili, E, Nolè, F, Tortora, G & Porta, C 2018, 'The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma', Anti-Cancer Drugs, vol. 29, no. 7, pp. 705-709. https://doi.org/10.1097/CAD.0000000000000632
Iacovelli, R. ; Cossu Rocca, M. ; Galli, L. ; Sabbatini, R. ; De Giorgi, U. ; Santini, D. ; Facchini, G. ; Mosca, A. ; Atzori, F. ; Zucali, P. ; Fornarini, G. ; Massari, F. ; Buti, S. ; Ricotta, R. ; Masini, C. ; Toscani, I. ; Biasco, E. ; Guida, A. ; Lolli, C. ; De Lisi, D. ; Rossetti, S. ; Terrone, C. ; Scartozzi, M. ; Miggiano, C. ; Pastorino, A. ; Bersanelli, M. ; Carlo-Stella, G. ; Pinto, C. ; Nobili, E. ; Nolè, F. ; Tortora, G. ; Porta, C. / The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma. In: Anti-Cancer Drugs. 2018 ; Vol. 29, No. 7. pp. 705-709.
@article{52a924b36d0b483ca089681b5ab8c2f9,
title = "The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma",
author = "R. Iacovelli and {Cossu Rocca}, M. and L. Galli and R. Sabbatini and {De Giorgi}, U. and D. Santini and G. Facchini and A. Mosca and F. Atzori and P. Zucali and G. Fornarini and F. Massari and S. Buti and R. Ricotta and C. Masini and I. Toscani and E. Biasco and A. Guida and C. Lolli and {De Lisi}, D. and S. Rossetti and C. Terrone and M. Scartozzi and C. Miggiano and A. Pastorino and M. Bersanelli and G. Carlo-Stella and C. Pinto and E. Nobili and F. Nol{\`e} and G. Tortora and C. Porta",
note = "Cited By :1 Export Date: 28 January 2019",
year = "2018",
doi = "10.1097/CAD.0000000000000632",
language = "English",
volume = "29",
pages = "705--709",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

AU - Iacovelli, R.

AU - Cossu Rocca, M.

AU - Galli, L.

AU - Sabbatini, R.

AU - De Giorgi, U.

AU - Santini, D.

AU - Facchini, G.

AU - Mosca, A.

AU - Atzori, F.

AU - Zucali, P.

AU - Fornarini, G.

AU - Massari, F.

AU - Buti, S.

AU - Ricotta, R.

AU - Masini, C.

AU - Toscani, I.

AU - Biasco, E.

AU - Guida, A.

AU - Lolli, C.

AU - De Lisi, D.

AU - Rossetti, S.

AU - Terrone, C.

AU - Scartozzi, M.

AU - Miggiano, C.

AU - Pastorino, A.

AU - Bersanelli, M.

AU - Carlo-Stella, G.

AU - Pinto, C.

AU - Nobili, E.

AU - Nolè, F.

AU - Tortora, G.

AU - Porta, C.

N1 - Cited By :1 Export Date: 28 January 2019

PY - 2018

Y1 - 2018

U2 - 10.1097/CAD.0000000000000632

DO - 10.1097/CAD.0000000000000632

M3 - Article

VL - 29

SP - 705

EP - 709

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 7

ER -